+ All Categories
Home > Documents > LIPID MAPS Annual Meeting 2013 Impact of …Register online at Early Registration Ends March 9, 2013...

LIPID MAPS Annual Meeting 2013 Impact of …Register online at Early Registration Ends March 9, 2013...

Date post: 30-Jun-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
1
Register online at www.lipidmaps.org Early Registration Ends March 9, 2013 May 7–8, 2013 // La Jolla, CA LIPID MAPS Annual Meeting 2013 Impact of Lipidomics on Oxidized Lipids and Non-Alcoholic Fatty Liver Disease Tuesday, May 7, 2013 Oxidized Lipids Oxidized metabolites of linoleic acid as biomarkers of liver injury in NASH Ariel Feldstein University of California, San Diego A novel strategy for oral ApoA-I mimetic therapy Alan M. Fogelman University of California, Los Angeles Genomics and lipidomics of macrophage activation Christopher K. Glass University of California, San Diego The effect of oxidized phospholipids on macrophage phenotype and function Norbert Leitinger University of Virginia Free radical oxidation of sterols and sterol esters in vitro and in vivo Ned A. Porter Vanderbilt University Genetic determinants of human plasma sterol levels David W. Russell UT Southwestern Medical Center Oxidized phospholipids in inflammation and atherogenesis Joseph L. Witztum University of California, San Diego Wednesday, May 8, 2013 Non-Alcoholic Fatty Liver Disease Molecular biomarkers in NAFLDs: An analysis of molecular species and pathways by the LIPID MAPS Consortium H. Alex Brown Vanderbilt University Mapping lipid pathways in mammalian biology by chemoproteomics and metabolomics Benjamin F. Cravatt III The Scripps Research Institute An emerging epidemic: Steatohepatitis and progression toward liver cancers D. Lee Gorden Vanderbilt University Nature + Nurture = NAFLD Helen Hobbs UT Southwestern Medical Center Molecular pathways leading to hepatic steatosis Jay Horton UT Southwestern Medical Center Sugar and fat: Methods, interesting findings, and remaining challenges for analysis of the (glyco)sphingolipidome Alfred H. Merrill, Jr. Georgia Institute of Technology Advances in mass spectrometry applied to lipid biochemistry Robert C. Murphy University of Colorado, Denver The spectrum of fatty liver disease: bench to bedside studies from the NASH Clinical Research Network Arun Sanyal Virginia Commonwealth University Meeting Supporters: LIPID MAPS and Annual Meeting Sponsors The LIPID MAPS Annual Meeting 2013 will focus on two key areas, Oxidized Lipids and Non-Alcoholic Fatty Liver Disease. There will be several speakers on each day and each section will include a panel discussion with the speakers on future directions, current roadblocks, and the LIPID MAPS studies. Plus: Poster sessions and several lightning talks selected from poster abstract submissions
Transcript
Page 1: LIPID MAPS Annual Meeting 2013 Impact of …Register online at Early Registration Ends March 9, 2013 May 7–8, 2013 // La Jolla, CA LIPID MAPS Annual Meeting 2013 Impact of Lipidomics

Register online at www.lipidmaps.org

Early Registration Ends March 9, 2013

May 7–8, 2013 // La Jolla, CA

LIPID MAPS Annual Meeting 2013

Impact of Lipidomics on Oxidized Lipids and Non-Alcoholic Fatty Liver Disease

Tuesday, May 7, 2013

Oxidized Lipids Oxidized metabolites of linoleic acid as biomarkers of liver injury in NASHAriel Feldstein University of California, San Diego

A novel strategy for oral ApoA-I mimetic therapyAlan M. Fogelman University of California, Los Angeles

Genomics and lipidomics of macrophage activationChristopher K. Glass University of California, San Diego

The effect of oxidized phospholipids on macrophage phenotype and functionNorbert Leitinger University of Virginia

Free radical oxidation of sterols and sterol esters in vitro and in vivoNed A. Porter Vanderbilt University

Genetic determinants of human plasma sterol levelsDavid W. Russell UT Southwestern Medical Center

Oxidized phospholipids in inflammation and atherogenesisJoseph L. Witztum University of California, San Diego

Wednesday, May 8, 2013

Non-Alcoholic Fatty Liver DiseaseMolecular biomarkers in NAFLDs: An analysis of molecular species and pathways by the LIPID MAPS ConsortiumH. Alex Brown Vanderbilt University

Mapping lipid pathways in mammalian biology by chemoproteomics and metabolomicsBenjamin F. Cravatt III The Scripps Research Institute

An emerging epidemic: Steatohepatitis and progression toward liver cancersD. Lee Gorden Vanderbilt University

Nature + Nurture = NAFLDHelen Hobbs UT Southwestern Medical Center

Molecular pathways leading to hepatic steatosisJay Horton UT Southwestern Medical Center

Sugar and fat: Methods, interesting findings, and remaining challenges for analysis of the (glyco)sphingolipidomeAlfred H. Merrill, Jr. Georgia Institute of Technology

Advances in mass spectrometry applied to lipid biochemistryRobert C. Murphy University of Colorado, Denver

The spectrum of fatty liver disease: bench to bedside studies from the NASH Clinical Research NetworkArun Sanyal Virginia Commonwealth University

Meeting Supporters:LIPID MAPS and Annual Meeting Sponsors

The LIPID MAPS Annual Meeting 2013 will focus on two key areas, Oxidized Lipids and Non-Alcoholic Fatty Liver Disease. There will be several speakers on each day and each section will include a panel discussion with the speakers on future directions, current roadblocks, and the LIPID MAPS studies.

Plus: Poster sessions and several lightning talks selected from poster abstract submissions

Recommended